BioSpace News Archive

Drug Development

FDA Greenlights BeiGene’s Brukinsa for Waldenstrom’s Macroglobulinemia

The approval was built on data from the Phase III ASPEN trial that compared Brukinsa to ibrutinib in a total of 201 patients. Here’s more about the drug.

September 2, 2021
·
3 min read
·
Alex Keown
Policy

FDA Crackdown on JAK Drug Class Unwelcome News for Pharma Giants

Henceforth, all JAK-inhibiting drugs like AbbVie’s Rinvoq, Pfizer’s Xeljanz, and Lilly’s Olumiant, have been ordered to include a warning label on the medicine to be sold in the U.S.

September 2, 2021
·
4 min read
·
BioSpace Editorial Staff
Drug Development

Vaccines Cut “Long-Haul” COVID Risk in Half, While Kids Test Positive in Droves

A study published in The Lancet Infectious Diseases found that the Pfizer-BioNTech, Oxford-AstraZeneca or Moderna vaccines resulted in a drop in “long-haul” COVID-19 by 50%.

September 2, 2021
·
3 min read
·
Mark Terry
Drug Development

Biotech Company Takes a Hit After Axing HBV Therapy over Safety Concerns

Shares of Assembly Biosciences have fallen more than 20% in premarket trading after the company discontinued the development of a hepatitis B therapeutic candidate.

September 2, 2021
·
2 min read
·
Alex Keown
Pharm Country

Angion to Participate in Upcoming September 2021 Investment Conferences

Angion Biomedica Corp announced its management team will present virtually at the H.C. Wainwright 23rd Annual Global Investment Conference and participate in a fireside chat with Oppenheimer Senior Biotech Analyst Justin Kim at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.

September 2, 2021
·
1 min read
Business

Sequana Medical announces H1 2021 results and provides business update

Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces its business highlights and financial results for the six-month period ending 30 June 2021 and its outlook for the remainder of the year and beyond.

September 2, 2021
·
20 min read
Neurosurgery Devices Market: The Neurostimulation Devices Segment is Projected to Account for Significant Share of the Market

Common neurological disorders include stroke, Parkinson’s disease, Alzheimer’s disease, Epilepsy, and multiple sclerosis.

September 2, 2021
·
6 min read
Medical Cyclotrons Market: Rise in Prevalence of Cancer is Expected to Drive the Market

A new era of nuclear medicine diagnosis has dawned with introduction of medical cyclotron technology.

September 2, 2021
·
5 min read
IV Infusion Pump Accessories Market: Trends, Opportunities & Regional Outlook 2018 - 2026

IV Infusion pumps are medicinal devices utilized to convey solutions and fluids into a patient’s body in controlled measurements.

September 2, 2021
·
5 min read
Hip Resurfacing Implants Market: Hybrid alloy segment currently holds a greater share in the market

Those having hip problems usually go for a hip replacement. They could also opt for hip resurfacing. The latter is a more conservative procedure having greater benefits.

September 2, 2021
·
5 min read